advanced search
PRODUCT SHOWCASE: ZwickRoell Parenteral Device Testing Platform
PREFILLED SYRINGES
Wolfgang Moersch
ZwickRoell
PRODUCT SHOWCASE: ZwickRoell Parenteral Device Testing Platform
ZwickRoell offers a wide variety of standardised test fixtures for parenteral devices including, described here: testing prefilled syringes to ISO 11040-4, -6 & -8; testing of Luer/Luer lock connections; serial, parallel and fully automatic syringe testing; and traceable, tamper-proof test results.
DEVELOPMENT OF A NEW HIGH-PERFORMANCE AUTOINJECTOR
INJECTION
Tom Oakley
Springboard
DEVELOPMENT OF A NEW HIGH-PERFORMANCE AUTOINJECTOR
Tom Oakley and Sigrid Saaler-Reinhardt discuss the development of the Midas Pharma’s NIS cartridge-based autoinjector.
PREFILLED SAFETY SYRINGE MARKET THRIVES AMID SELF-ADMINISTRATION TREND
EXPERT VIEW
George I’ons
PREFILLED SAFETY SYRINGE MARKET THRIVES AMID SELF-ADMINISTRATION TREND
George I’ons looks at how the growing trend of patient self-administration is driving demand for prefilled safety syringes.
LARGE-VOLUME INJECTORS: RISE IN BIOLOGICS BRINGS CHALLENGES
EXPERT VIEW
Dr Paolo Fiorini
LARGE-VOLUME INJECTORS: RISE IN BIOLOGICS BRINGS CHALLENGES
Developing devices capable of delivering highly viscous biologic drug formulations at high volumes does not come without its challenges. Paolo Fiorini, Gerard Linnane, Michael Kiely, Maciej Grygorczuk and Joshua Coyne discuss these challenges and the merits of various drive solutions.
LEVERAGING THE PATIENT JOURNEY TO OPTIMISE DEVICE USE AT HOME
INJECTION
Séverine Duband
Nemera
LEVERAGING THE PATIENT JOURNEY TO OPTIMISE DEVICE USE AT HOME
Séverine Duband and Mark Tunkel discuss the importance of device optimisation to increase patient safety during self-administration of medication.
ADDRESSING THE EVOLVING NEEDS OF VARIABLE DRUG DELIVERY REGIMENS
WEARABLES
Dr Temitope Sodunke
BD (Becton Dickinson & Company)
ADDRESSING THE EVOLVING NEEDS OF VARIABLE DRUG DELIVERY REGIMENS
Temitope Sodunke introduces the BD Evolve™ On-body Injector and describes how the device is designed specifically to address the rapidly evolving needs of the pharma industry and meet patient requirements.
HOW TO DESIGN A BODY-WORN INJECTOR
EXPERT VIEW
Steve Augustyn
HOW TO DESIGN A BODY-WORN INJECTOR
Body-worn injectors require you to understand your user, your drug and your technology – and there are numerous pitfalls for the unwary. Stephen Augustyn shares some insights.
THE NEED FOR CSTDS IN BOTH MANUAL AND AUTOMATED COMPOUNDING
INJECTION
Marino Kriheli
Equashield
THE NEED FOR CSTDS IN BOTH MANUAL AND AUTOMATED COMPOUNDING
Marino Kriheli discusses the benefits of using closed system transfer devices (CSTDs) in both manual and automated hazardous drugs compounding.
FINDING THE RIGHT PACKAGING FOR BIOLOGIC DRUGS
PREFILLED SYRINGES
Christian Helbig
SCHOTT Pharma
FINDING THE RIGHT PACKAGING FOR BIOLOGIC DRUGS
Christian Helbig introduces a new 2.25 mL version of SCHOTT’s syriQ BioPure® prefillable syringes designed specifically for the biologics market and, developed in partnership with WL Gore, the world’s first silicone-free glass syringe system.
THE CHALLENGES OF A CHANGING MARKET & THE BENEFITS OF DEVELOPMENT FLEXIBILITY
INJECTION
David Fink
Ximedica
THE CHALLENGES OF A CHANGING MARKET & THE BENEFITS OF DEVELOPMENT FLEXIBILITY
David Fink and Sheila Trgovac describe how adopting a flexible development model in mid-to-late development brings benefits through to commercialisation, especially in the context of a changing market.
VIDEO: Credence Connect from Credence MedSystems
VIDEO
John Merhige
Credence MedSystems
VIDEO: Credence Connect from Credence MedSystems
Credence MedSystems takes us through the use steps of its new Credence Connect™ autosensing injection system, and smartphone app.
INTERVIEW WITH DR SRI MUDUMBA, SANTEN & DR GAUTAM SHETTY, CONGRUENCE
INTERVIEW
Dr Gautam N Shetty
Congruence Medical Solutions
INTERVIEW WITH DR SRI MUDUMBA, SANTEN & DR GAUTAM SHETTY, CONGRUENCE
In this interview, Dr Sri Mudumba, Santen, and Dr Gautam N Shetty, Congruence Medical Solutions, share insights from their experience of working together in developing the MDS for ophthalmic injections.
OPTIMISING OPHTHALMIC DRUG DELIVERY FOR THERAPEUTIC EFFECTIVENESS
EXPERT VIEW
Dr Barbara Morgan
OPTIMISING OPHTHALMIC DRUG DELIVERY FOR THERAPEUTIC EFFECTIVENESS
Barbara Morgan discusses how eye physiology impacts product formulation and choice of dosage form, and how advanced delivery technologies are providing new options for formulators seeking to improve the bioavailability or stability of their ophthalmic treatments.
DEVELOPING AN EFFICIENT OPHTHALMIC DEVICE COMBINATION PRODUCT
OCULAR
Zoe Davidson
Nemera
DEVELOPING AN EFFICIENT OPHTHALMIC DEVICE COMBINATION PRODUCT
Zoë Davidson looks at how understanding the patient journey can help develop an efficient ophthalmic device combination product.
DELIVERING ON THE GROWING NEED FOR TOPICAL PRESERVATIVE-FREE OPHTHALMIC TREATMENTS
OCULAR
Matthias Birkhoff
Aptar Pharma
DELIVERING ON THE GROWING NEED FOR TOPICAL PRESERVATIVE-FREE OPHTHALMIC TREATMENTS
Matthias Birkhoff provides an overview of existing ophthalmic delivery technologies and progress made within topically applied medications – and introduces a new market standard for testing microbial integrity in preservative-free formulation.
ADVANCED DRUG DELIVERY FOR DRY EYE TREATMENT
OCULAR
Rouven Kraus
Aero Pump
ADVANCED DRUG DELIVERY FOR DRY EYE TREATMENT
Rouven Kraus and Wilfried Woesthuis discuss Aero Pump and Medspray's new open-eye spray for the treatment of dry eyes.
HOW TO DEVELOP A CUSTOMISED IOT PLATFORM WITH A RUNNING START
CONNECTIVITY
Rachel An
Quantex Arc
HOW TO DEVELOP A CUSTOMISED IOT PLATFORM WITH A RUNNING START
Do you need a drug delivery Internet of Things (IoT) platform across your entire portfolio of drugs that is agnostic to the type of source container, drug viscosity and the volume to be dispensed? Rachel An and Gillian Harding-Moore discuss how to develop such a platform with a running start.
THE TRUSTED TABLET: A NEW LEVEL OF SUPPLY CHAIN SECURITY FROM MASS DIGITALISATION OF MEDICINES
CONNECTIVITY
Kelly Boyer
Colorcon
THE TRUSTED TABLET: A NEW LEVEL OF SUPPLY CHAIN SECURITY FROM MASS DIGITALISATION OF MEDICINES
Kelly Boyer, Trent Lund and Barry McDough describe a means of mass digitalising medicines to address the problem of illegal and unauthorised production of pharmaceutical products in a meaningful way.
A FLEXIBLE, MODULAR PLATFORM TO DISRUPT THE BLOCKBUSTER MANUFACTURING MODEL
EARLY INSIGHT
Nick Rollings
BiologIC Technologies
A FLEXIBLE, MODULAR PLATFORM TO DISRUPT THE BLOCKBUSTER MANUFACTURING MODEL
Nick Rollings, Colin Barker and Richard Vellacott discuss the drug delivery scenario in the advanced therapy (AT) era, examining how the current slow-moving blockbuster treatment model is making way for a fast-moving, patient-focused era of personalised medicine
NEXT-GENERATION CONNECTED DRUG DELIVERY SUPPORTS DATA LIQUIDITY & COST SAVINGS
CONNECTIVITY
Neil Williams
Phillips-Medisize
NEXT-GENERATION CONNECTED DRUG DELIVERY SUPPORTS DATA LIQUIDITY & COST SAVINGS
Neil Williams discusses medication non-adherence, the toll it takes on the healthcare system and how integration, analytics and more affordable connectivity in drug delivery devices as part of a connected health ecosystem improves patient care and lowers costs.
AN INJECTION OF CONNECTED NEEDLE-FREE INNOVATION
CONNECTIVITY
Barbara Taylor
Portal Instruments
AN INJECTION OF CONNECTED NEEDLE-FREE INNOVATION
Barb Taylor discusses the next generation of needle-free injection devices, which incorporate connectivity.
TRANSFORMING HEALTHCARE – HOW CURATIVE THERAPIES WILL DISRUPT THE MARKET
EXPERT VIEW
Dr Ulrica Sehlstedt
TRANSFORMING HEALTHCARE – HOW CURATIVE THERAPIES WILL DISRUPT THE MARKET
Ulrica Sehlstedt, Craig Wylie, Thomas Unger, Rebecka Axelsson Wadman, Vikas Kharbanda, and Satoshi Ohara, all members of Arthur D. Little’s Healthcare and Life Sciences Practice, explain how the shift to curative treatments promises to transform the entire healthcare ecosystem. 
THE CURRENT STATE OF PLAY IN CONNECTED DEVICES
CONNECTIVITY
Marcus Bates
Aptar Pharma
THE CURRENT STATE OF PLAY IN CONNECTED DEVICES
Marcus Bates; Joachim Koerner and Jerôme Prraquin discuss the current state of play, what connected device advocates are doing to enable faster implementation, and how we can optimise connected technology while reducing the cost and improving human factors.
CHOOSING THE RIGHT CONNECTIVITY FOR DRUG DELIVERY AND MEDICAL PRODUCTS
EXPERT VIEW
Dr Juan Nogueira
CHOOSING THE RIGHT CONNECTIVITY FOR DRUG DELIVERY AND MEDICAL PRODUCTS
Juan Nogueira; Tommaso Borghi and Marco Vergani discuss the factors that need to be taken into account in the selection of connectivity technology for a drug delivery device or other medical product.

See what ondrugdelivery's readers and contributors think


Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.


Donna Bibber
President
Micro Engineering Solutions

I picked up your latest copy at the Boston PODD event and read it with great interest. You’ve really come a long way and you put out an amazingly professional and value-packed magazine.


Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.


Abby Lockwood Opus Strategy photo
Abby Lockwood
Consultant
Plan Strategic

ONdrugDelivery Magazine is a great resource that brings a lot of value to the work my team and I are doing in the area of drug delivery. The device-specific content as well as the broader discussions surrounding industry trends and issues are extremely informative and very well written.


Top